NASDAQ (USD): Kura Oncology, Inc. (KURA)
Last Price
10.80
Today's Change
+0.74 (7.35%)
Day's Change
9.95 - 11.17
Trading Volume
6,864,010
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
Hyundai unveils Big Electric SUV in Fast-growing Market
2
Starbucks Shrank Retail Staff 8% Despite Hundreds of New Stores
3
Full US DOJ Statement on Billionaire Gautam Adani’s Indictment on Bribery Charges
4
Bitcoin Climbs Closer to US$100,000 on Trump’s Support for Crypto
5
Starbucks Said to Consider Selling Stake in Chinese Business
#
Stock
Score
META
Meta Platforms, Inc.
AGN
882
TSLA
Tesla, Inc.
PFE
Pfizer Inc.
IRM
Iron Mountain Incorporated
588
6
LRN
Stride, Inc.
7
ESLT
Elbit Systems Ltd.
8
FB
9
GMLP
10
SE
Sea Limited
411
Last
Change
Volume
MSTZ
0.947
-0.123
793,093,386
SLNA
0.03
-0.008
379,091,456
CYXT
0.065
0.00
369,807,727
ELAB
0.02
355,914,415
UWT
0.164
-0.002
244,137,454
NVDA
141.95
-4.72
229,871,933
AGIL
0.197
+0.114
206,404,986
LYLT
0.218
204,480,452
ZNGA
8.18
-0.17
184,885,916
BBBY
0.075
-0.028
174,510,874
BRK-A
714,280.00
+7,030.00
1,527
TPL
1,730.00
+214.47
684,816
RTLA
209.90
+74.87
0
NVR
9,007.24
+60.71
22,890
MELI
2,005.00
+36.85
411,200
ACSG
33.28
+33.28
99,050
MKL
1,750.00
+31.55
35,256
EMSA
140.77
+30.77
AZO
3,099.38
+30.69
123,079
EMLB
80.80
+30.30
1,774.05
-343.25
2,940,447
MPWR
592.31
-168.99
175,940
MSTR
1,309.00
-138.99
2,237,917
1,395.13
-102.30
318,280
LOWC
30.18
-92.412
1,236,074
NOW
643.29
-87.83
5,025,012
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....